Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study.
Jesús Peña-MartínMaría Belén García-OrtegaJosé Luis Palacios-FerrerCaridad DíazMaría Ángel GarcíaHouria BoulaizJavier ValdiviaJosé Miguel JuradoFrancisco M Almazan-FernandezSalvador Arias SantiagoFrancisca VicenteCoral Del ValJosé Pérez Del PalacioJuan Antonio Marchal CorralesPublished in: The British journal of dermatology (2024)
These results demonstrate that metabolomics using LC-HRMS is a powerful tool to identify and quantify metabolites in bodily fluids that could serve as potential early diagnostic markers for MM.